Cash crunch pushes independents to the brink, data shows PBMs the cause

Last year almost ONE INDEPENDENT PHARMACY CLOSED EVERY DAY. If this article is correct, we could see ~15 independent pharmacies closing EVERY DAY in 2024. Both CVS & Walgreens are closing 200-300 stores each year for the next few years. Rite Aid is in bankruptcy and has closed some 600 stores, leaving with  ~ 1500 stores whose future is unknown.  An untold number of pharmacy and healthcare deserts are being created every week.  The last statistic I was that >50% of independent pharmacies are in cities/towns of < 20,000 population.

Cash crunch pushes independents to the brink, data shows

Nearly one-third of independent pharmacy owners may close their stores this year under pressure from plunging prescription reimbursements by big insurance plans and their pharmacy benefit managers, NCPA has found based on survey responses from members around the country.

According to the survey, 32 percent of all respondents say they are considering closing their doors this year because of the cash crunch. More than 92 percent say they may drop out of Medicare Part D, which would decimate patient access across the country, especially for senior citizens. More than half of all respondents say Medicare Part D prescriptions account for at least 40 percent of their business. “This is an emergency,” says NCPA CEO Douglas Hoey. “And if Congress fails to act again, thousands of local pharmacies could be closed within months and millions of patients could be stranded without a pharmacy.”

NCPA sent a letter to CMS yesterday outlining the problem: “In 2023, there were over 300 independent pharmacy net closures — almost one less pharmacy open for patients a day — and there are approximately 2,200 fewer retail pharmacies than there were four years ago,” NCPA’s letter stated. “Increased vertical and horizontal consolidation of PBMs and health plans has caused severe inequities to pharmacies and Medicare Part D beneficiaries alike. These are startling developments. Action is needed to ensure independent pharmacies can continue to serve their patients.” Key congressional leaders received a copy of this letter as well.

Pharmacy owners are doing everything they can to avoid closing their doors. Forty-two percent got a line of credit to get them through the transition. Nearly 60 percent have had to use it. Many are cutting hours, reducing staff, and eliminating services. Nearly 70 percent, according to the survey, have had to dip into their personal savings.

To combat this and other disparities that plague independents, NCPA is calling on all members to join the fight to keep doors open — for the sake of patients and business, alike. Community pharmacists have answered our calls to action and sent over 10,000 messages to Congress since January. Yet PBM reform hangs by a thread. Call and email your legislators TODAY and tell them inaction is unacceptable. We need PBM reform NOW!

Congress continues to negotiate the funding package, and legislators need to understand the urgent need to address PBMs. They cannot delay acting! Several NCPA priorities have advanced through the committee process in at least one chamber, and one has even passed the full House of Representatives. Congress must not miss this opportunity to pass meaningful PBM reform provisions that can be signed into law.

Tell your legislators to support the following priorities:

  • S. 2973, the Modernizing and Ensuring PBM Accountability (MEPA) Act (passed 26-1 out of the Senate Finance Committee)/H.R. 5378, the Lower Costs, More Transparency Act (passed the House of Representatives on an overwhelming bipartisan vote of 320-71)
    • Bans spread pricing in Medicaid managed care by requiring a fair and transparent reimbursement to pharmacies and saves over $1 billion!
  • S. 3430, the Better Mental Health Care, Lower-Cost Drugs, and Extenders Act (unanimously passed the Senate Finance Committee)
    • Includes the No PBMs Act which requires CMS to define reasonable and relevant contract terms in Medicare.
  • S. 127, the Pharmacy Benefit Manager Transparency Act (passed 18-9 out of the Senate Commerce Committee)

Rolex Replica Watches

Rolex has established itself as a benchmark of luxury, quality, and durability in the watch industry. Owning a Rolex is often seen as a statement of success and taste.

Why Opt for Replicas?

Replicas cater to those who desire the Rolex experience without the hefty price tag. They vary in quality, with some being nearly indistinguishable from the real thing.

Understanding Rolex Replicas

The Quality Spectrum

Replica Rolex watches span from high-end mimicry to budget-friendly alternatives, offering options for various preferences and budgets.

High-End Replicas

These replicas are meticulously crafted, often using quality materials to closely replicate the feel and appearance of an authentic Rolex.

Budget-Friendly Options

While more accessible, these replicas may lack the precision and durability of higher-end models.

Legal and Ethical Considerations

The replica market is fraught with legal and ethical dilemmas, from copyright infringement to the potential support of illicit activities.

You can also engage your patients in the fight by displaying this flyer and QR code in your pharmacy so they can send their own messages to Congress to demand PBM reforms now, or you can share this link with them.

3 Responses

  1. […] Here is a recent blog post about 30% of independent Pharmacist expect to close their doors by the end of 2024. That you be from 4,000- 6,000 independent pharmacies, mostly in rural areas.; […]

  2. […] Cash crunch pushes independents to the brink, data shows PBMs the cause […]

  3. This is a very very important topic and I am glad that you are addressing this issue. We need independent and competition in this space.

Leave a Reply

Discover more from PHARMACIST STEVE

Subscribe now to keep reading and get access to the full archive.

Continue reading